Back to top

Investors are Betting Against Ironwood Pharmaceuticals, Inc. (IRWD), Should You?
August 22, 2013

Read MoreHide Full Article

Many investors appear to be quite bearish on Ironwood Pharmaceuticals, Inc. (IRWD - Free Report) , especially if you look at the percentage of the float that is sold short for this stock. Currently, 27.91% of the float is sold short, suggesting an extreme level of bearishness for IRWD.

However, it is worth noting that earnings estimates have actually been moving higher for the company, despite the pessimism. Thanks to these rising estimates, we actually have a Zacks Rank #2(Buy) on IRWD, so we clearly don’t believe in the negativity surrounding this firm, and are instead looking for shares of IRWD to move higher in the weeks ahead.

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Ironwood Pharmaceuticals, Inc. (IRWD) - free report >>

More from Zacks Tale of the Tape

You May Like